Average Insider

Where insiders trade, we follow

$ONCO
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
Healthcare
Sector
Biotechnology
Industry
Neil J. Campbell MA, MBA
CEO
12
Employees
$0.75
Current Price
$3.41M
Market Cap
52W Low$0.67
Current$0.750.1% above low, 99.9% below high
52W High$74.38

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys12$127,590.54166,904All Buys
Sells00--
2 weeksBuys12$127,590.54166,904All Buys
Sells00--
1 monthBuys12$127,590.54166,904All Buys
Sells00--
2 monthsBuys12$127,590.54166,904All Buys
Sells00--
3 monthsBuys12$127,590.54166,904All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Apr 15, 2026
HRT FINANCIAL LP
10% Owner
Purchase92,554$0.76$70,341.04View Details
Apr 14, 2026
HRT FINANCIAL LP
10% Owner
Purchase74,350$0.77$57,249.50View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Mar 12, 2026
EPS
EstimatedN/A
Actual$6.05
Revenue
EstimatedN/A
Actual$303.60K
1 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.3.33